Ligand · WM9
WM9 · (2S)-2-[3-(3-chlorophenyl)phenyl]-2-methyl-5,6-dihydro-1,3-oxazin-4-amine
WM9, (2S)-2-[3-(3-chlorophenyl)phenyl]-2-methyl-5,6-dihydro-1,3-oxazin-4-amine (C17 H17 Cl N2 O, 300.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- WM9
- Formula
- C17 H17 Cl N2 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
WM9 in 2 structures; the first of them:
- 4B70 · Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain · WM9 A1503 · binds SER10, GLY11, GLN12, GLY13, LEU30, ASP32, GLY34, SER35 and 10 more
- 4B70 · Aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain · WM9 A1503 · binds SER10, GLY11, GLN12, GLY13, LEU30, ASP32, GLY34, SER35 and 10 more
Residues it binds most
GLY 2, SER 2, ASP 2, ILE 2, THR 2, GLN 2, LEU 2, PHE 2, TRP 2, TYR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.